The male mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 in Togo is currently 26.8%, a decrease of 0.2% (-0.7%) compared to 2018.
Male mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Togo
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Togo
Male CVD, cancer, diabetes or CRD
More indicators for Togo
Out-of-pocket expenditure PPP per capita
intl dollar90
+intl dollar5
(2021)
Newborns protected against tetanus
83%
-2%
(2022)
Female wasting in children
5.3%
-0.3%
(2017)
Birth registration
82.9%
+4.9%
(2017)
Female prevalence of HIV
0.8%
0%
(2022)
Contraceptive modern method prevalence
21.4%
+4.1%
(2017)
Togo Male CVD, cancer, diabetes or CRD between 2000 and 2019
| Period | Male CVD, cancer, diabetes or CRD | Change |
|---|---|---|
| 2019 | 26.8% | -0.2% |
| 2018 | 27% | -0.6% |
| 2017 | 27.6% | -0.5% |
| 2016 | 28.1% | -0.7% |
| 2015 | 28.8% | -0.6% |
| 2014 | 29.4% | -0.5% |
| 2013 | 29.9% | -0.3% |
| 2012 | 30.2% | -0.3% |
| 2011 | 30.5% | -0.4% |
| 2010 | 30.9% | -0.4% |
| 2009 | 31.3% | -0.3% |
| 2008 | 31.6% | +0.2% |
| 2007 | 31.4% | +0.1% |
| 2006 | 31.3% | +0.3% |
| 2005 | 31% | +0.1% |
| 2004 | 30.9% | 0% |
| 2003 | 30.9% | +0.7% |
| 2002 | 30.2% | +0.1% |
| 2001 | 30.1% | +0.4% |
| 2000 | 29.7% |